Research

Research at Boston Children's Hospital

The research enterprise at Boston Children’s Hospital, comprising more than 3,000 researchers, is the world’s largest at a pediatric center. Our work is fueled by a deep understanding of disease coupled with world-class discovery platforms, including genetics and genomics, gene editing, bioinformatics, proteomics, bioengineering, image analysis, multiple animal models, biobanks and disease-specific stem cell lines. We have special expertise in rare disease discovery and see large, highly diverse patient populations.

michael rogers and danielle peterse

Find a Researcher

More than 3,000 researchers & scientific staff

Find a Researcher
find a Boston Children

Research Labs

1 million square feet of research space — and growing

Find a Center or Lab
explore Boston Children

Explore Research Topics

$388 million in total research funding FY2018 — #1 NIH funding for pediatric research

Find a Topic

Going into science: Women scientists at Boston Children's offer advice to girls

We gathered women scientists from across Boston Children’s Hospital and asked them to advise girls wanting to enter the field. Hear what they had to say, and go in depth here for more wise words and a taste of what they’re investigating.

Boston Children's Hospital Innovation

BCH Innovation News @BCH_Innovation 1/27/2021 3:00:06 PM
We are excited to share the launch of @OutbreaksNearMe, a crowdsource surveillance system that tracks #COVID19 and… https://t.co/1TeIONqGIl
BCH Innovation News @BCH_Innovation 1/26/2021 9:00:01 PM
Therapy developed at Boston Children’s stops #preeclampsia before it starts: https://t.co/cck2nSbpoi https://t.co/RgW28ouA0C
BCH Innovation News @BCH_Innovation 1/26/2021 2:00:01 PM
#Exosomes secreted by mesenchymal stromal cells (#MEx) prevented maternal symptoms of preeclampsia and fetal growth… https://t.co/vxxmAApTJU
BCH Innovation News @BCH_Innovation 1/25/2021 9:30:00 PM
“We were excited that our study also showed improvement in the fetus,” says Elizabeth Taglauer on the finding that… https://t.co/46l5JlbIQy
BCH Innovation News @BCH_Innovation 1/25/2021 7:00:07 PM
The immune-suppressing drug #abatacept, currently used for rheumatoid arthritis, could make bone marrow transplant… https://t.co/BSPTbyQVm8
BCH Innovation News @BCH_Innovation 1/25/2021 6:30:00 PM
Compounds made naturally by the body called #MEx (Mesenchymal stromal cell Extracellular vesicles)shown to prevent… https://t.co/q21LGW1Ubm
Building on our extraordinary leadership in pediatric science at Boston Children’s, we translate our findings — and those of others — to fundamentally change how disease is treated and cured.

David A. Williams, MD
Senior Vice President and Chief Scientific Officer